Navigation Links
El Proyecto Recuperación transforma hemoderivados en medicina para la hemofilia en países en desarrollo
Date:9/26/2013

encia y las sólidas relaciones con todos aquellos que nos han impulsado hasta ahora ayudarán a miles de pacientes que merecen tratamiento".

Esta donación de Haemoctin supone un hito para la WFH. El proyecto permitirá a la WFH ampliar su Programa de Ayuda Humanitaria como parte de sus exhaustivas actividades para hacer realidad el tratamiento de todas las personas con trastornos hemorrágicos.

Acerca de la hemofilia y otros trastornos hemorrágicos
La hemofilia, la enfermedad de von Willebrand, las alteraciones heredadas de plaquetas y otras deficiencias de factor constituyen trastornos hemorrágicos de por vida que impiden la correcta coagulación de la sangre. Las personas que sufren un trastorno de coagulación no tienen determinado factor de coagulación o una proteína en sangre que controla las hemorragias en cantidades suficientes, o bien no funcionan adecuadamente. La gravedad de un trastorno hemorrágico suele depender del faltante o la inoperatividad del factor coagulante alterado. Las personas con hemofilia pueden padecer hemorragias no controladas derivadas de heridas de aparentemente poca importancia. El sangrado al interior de articulaciones y músculos es sumamente doloroso y puede causar discapacidad, mientras que el sangrado al interior de órganos importantes, como el cerebro, puede provocar la muerte.

Acerca de BIOTEST AG
BIOTEST se especializa en la hematología y la inmunología innovadoras gracias a un enfoque integral de un grupo de productos farmacéuticos y de bioterapia que operan en todo el mundo, y desarrolla, fabrica y vende productos medicinales para el tratamiento de trastornos de la sangre y del sistema inmunológico. El principal material de base para los productos farmacéuticos de BIOTEST es el plasma humano; este se procesa para fabricar productos medicinales empleados en el tratamiento de alteraciones que ponen en riesgo
'/>"/>

SOURCE World Federation of Hemophilia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field
2. Transformation Dental Partners Launch Ground Breaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
3. Industry Thought Leader to Present Transformational Opportunities for Industry Adoption of Advanced Analytics at 2013 HIMSS Annual Conference & Exhibition
4. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... FRANCISCO, Calif. , Aug. 31, 2015 ... discovery and development of novel cancer immunotherapies, announced today ... Ph.D., as Chief Executive Officer and William Ho ... and Ho join an experienced management team led by ... Jordan Fridman , Ph.D., Chief Scientific Officer; Jay ...
(Date:8/31/2015)... 2015 Trimb Healthcare AB ("Trimb") today announced ... Group BV ("YouMedical"), a Dutch OTC company with operations ... of approximately EUR 16 million, with solid growth and ... ambition is to build a leading international OTC company, ... goal. YouMedical gives us a stronger North European OTC ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... the world's most successful food and beverage processors, equipment manufacturers and leaders in ... product inspection and industrial weighing and formulation for manufacturers of bakery and snacks; ...
(Date:8/31/2015)... ... ... Proove Biosciences, Inc. is a finalist for the Outstanding Tech Company category of ... its 22nd year, this premier awards event celebrates the best in Orange County’s technology ... world. The OC Tech Alliance will announce all winners at a gala dinner on ...
Breaking Biology Technology:FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4METTLER TOLEDO Hosts Food Safety Educational Center at 2015 PROCESS EXPO 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4
... Johnson & Johnson today announced that Axel Ullrich, ... the Max Planck Institute of Biochemistry in Germany, whose ... (trastuzumab)*, is the winner of the 2009 Dr. Paul ... world-renowned scientists selected Dr. Ullrich, who on September 8 ...
... Only 15th Chief Master Sergeant in Air Force History Appointed ... Va., July 1 MicroTech announced today that ... McKinley has joined the company as MicroTech,s Vice President of ... network and IT enterprise management providers in the U.S. In ...
... WAYNE, Pa., July 1 Encorium Group, Inc. ... multinational contract research organization (CRO) that provides design, development, ... to many of the world,s leading pharmaceutical companies, today ... previously announced letter of intent with Pierrel SpA, an ...
Cached Biology Technology:Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 2Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 2Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 3Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business 4
(Date:8/18/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ) ... Biometric Authentication & Identification Market: Focus On Modality, ... report to their offering. ... is expected to grow at an estimated CAGR ... over $25 billion (approximately) by 2020 as per ...
(Date:8/12/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is proud to announce that iMedNet ... technology platform, has led the way to significant and ... 2015.   Q2 2015 and Q1 2015 were, respectively, ... value sold in the company,s 15 year history.  In ...
(Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
... of gold so small that they can,t be seen ... products and as pharmaceuticals to fight cancer. Despite their ... dangerous and extremely toxic chemicals. While the nanotechnology industry ... the near future, researchers have been worried about the ...
... have developed a plug-in interface for the microfluidic chips that will ... They hope that the "fit to flow" interface will become as ... Davis filed a provisional patent on the invention Nov. 1. A ... journal Lab on a Chip . "We think ...
... The American Epilepsy Society (AES) 64th Annual Meeting, ... with seizures and epilepsy, will take place December 3 ... Center, San Antonio. , A series of ... through Tuesday morning, December 7. Place: Henry ...
Cached Biology News:Cinnamon can replace harmful chemicals used to create nanoparticles 264th American Epilepsy Society Annual Meeting 264th American Epilepsy Society Annual Meeting 3
Request Info...
Request Info...
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
... Versatile state of the Art GLP ... to dual 38,000 L fermentation. ... to production. Aseptic operation capable ... Fed-Batch, and Continuous Modes. Hosts ...
Biology Products: